NEXIMMUNE

neximmune-logo

NexImmune is an early stage biopharmaceutical company developing novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. The AIM technology provides an important advance in the development of immunotherapies for a variety of cancers and other diseases. The AIM technology has been designed to orchestrate specific immune system responses in a highly controllable and reproducible way independent of the healthiness or abundance of the patientโ€™s natural antigen presenting cell (APC) population. Natural APCs are major players in the bodyโ€™s immune system as they direct the immune system cells in attacks on specifically targeted antigens and cells. However, under certain disease conditions, natural APCs can be damaged, absent or inactive.

#SimilarOrganizations #People #Financial #Event #Website #More

NEXIMMUNE

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2011-01-01

Address:
Gaithersburg, Maryland, United States

Country:
United States

Website Url:
http://www.neximmune.com

Total Employee:
11+

Status:
Active

Contact:
3018610009

Email Addresses:
[email protected]

Total Funding:
210.27 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.


Current Advisors List

kenneth-carter_image

Kenneth Carter Chairman @ NexImmune
Board_member

Current Employees Featured

john-trainer_image

John Trainer
John Trainer Chief Financial Officer @ NexImmune
Chief Financial Officer

bob-knight_image

Bob Knight
Bob Knight Chief Medical Officer @ NexImmune
Chief Medical Officer

scott-carmer_image

Scott Carmer
Scott Carmer COO @ NexImmune
COO
2014-01-01

daniel-bednarik_image

Daniel Bednarik
Daniel Bednarik Executive Consultant @ NexImmune
Executive Consultant
2015-06-01

kristi-jones_image

Kristi Jones
Kristi Jones Chief Executive Officer @ NexImmune
Chief Executive Officer
2022-02-01

mathias-oelke_image

Mathias Oelke
Mathias Oelke Chief Scientific Officer @ NexImmune
Chief Scientific Officer
2022-04-01

Founder


jonathan-schneck_image

Jonathan Schneck

Stock Details


Company's stock symbol is NASDAQ:NEXI

Investors List

irving-investors_image

Irving Investors

Irving Investors investment in Convertible Note - NexImmune

barer-son-capital_image

Barer & Son Capital

Barer & Son Capital investment in Series A - NexImmune

piedmont-capital-partners_image

Piedmont Capital Partners

Piedmont Capital Partners investment in Series A - NexImmune

arrowpoint-partners_image

ArrowMark Partners

ArrowMark Partners investment in Series A - NexImmune

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Venture Round - NexImmune

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - NexImmune

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Venture Round - NexImmune

Official Site Inspections

http://www.neximmune.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.36 K

  • Host name: 209.182.196.106
  • IP address: 209.182.196.106
  • Location: Los Angeles United States
  • Latitude: 33.956
  • Longitude: -118.3887
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90045

Loading ...

More informations about "NexImmune" on Search Engine